![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BIOSENSE WEBSTER RECEIVES THE 2006 FROST & SULLIVAN AWARD FOR EXCELLENCE IN TECHNOLOGY FOR ITS CARDIAC ABLATION SYSTEMS
BIOSENSE WEBSTER RECEIVES THE 2006 FROST & SULLIVAN AWARD FOR EXCELLENCE IN TECHNOLOGY FOR ITS CARDIAC ABLATION SYSTEMS
August 11, 2006
Frost & Sullivan selected Biosense Webster, Inc. as the recipient of its 2006 Excellence in Technology Award in the cardiac rhythm management market for its longstanding commitment to developing clinically safe and complete cardiac ablation systems. The company is known for its exceptional technologies in the electrophysiology (EP) diagnostic, therapeutic, and electroanatomic cardiac mapping industry. WebWire (http://webwire.com/ViewPressRel.asp?SESSIONID=&aId=18130)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct